194 related articles for article (PubMed ID: 33871216)
1. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
2. Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma.
Kang HJ; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Int J Dermatol; 2020 Oct; 59(10):1249-1257. PubMed ID: 32720336
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site.
Jung JM; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Pathology; 2020 Oct; 52(6):670-675. PubMed ID: 32819739
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
5. Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.
Choi ME; Jung JM; Kim DH; Won CH; Chang SE; Lee MW; Lee WJ
J Am Acad Dermatol; 2024 May; 90(5):977-985. PubMed ID: 38272394
[TBL] [Abstract][Full Text] [Related]
6. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study.
Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Ferrándiz C
Dermatol Surg; 2009 Oct; 35(10):1505-13. PubMed ID: 19686364
[TBL] [Abstract][Full Text] [Related]
7. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of tumor-infiltrating lymphocytes and programmed death-1 expression in cutaneous melanoma: a comparative study on clinical subtypes.
Lee WJ; Lee YJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Melanoma Res; 2018 Oct; 28(5):423-434. PubMed ID: 29634635
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of acral melanoma: a series of 281 patients.
Bello DM; Chou JF; Panageas KS; Brady MS; Coit DG; Carvajal RD; Ariyan CE
Ann Surg Oncol; 2013 Oct; 20(11):3618-25. PubMed ID: 23838913
[TBL] [Abstract][Full Text] [Related]
10. Limb melanomas: acral melanomas have worse survival.
Tas F; Erturk K
J Dermatolog Treat; 2022 May; 33(3):1630-1637. PubMed ID: 33470132
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
13. Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis.
Cho KK; Cust AE; Foo YM; Long GV; Menzies AM; Eslick GD
Melanoma Res; 2021 Oct; 31(5):482-486. PubMed ID: 34433196
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
15. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
17. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
Lim Y; Lee J; Lee DY
J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
[TBL] [Abstract][Full Text] [Related]
18. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract][Full Text] [Related]
19. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
20. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma.
Castaneda CA; Castillo M; Torres-Cabala C; Bernabe LA; Casavilca S; Villegas V; Sanchez J; de la Cruz M; Dunstan J; Cotrina JM; Gomez HL; Chavez C; Landa-Baella MP; Tello K; Felix BF; Abugattas J
Clin Transl Oncol; 2019 Sep; 21(9):1127-1134. PubMed ID: 30778854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]